How do you nail down the definition of contemporary? Ask an expert like Suzanne DeRusha, president of Suzanne Kimberly Design. In this episode of Element Sessions, an Element Designs podcast, host Sean Heath explored the fundamental principles of creating successful contemporary designs with the noted designer.
So, does contemporary design have a firm or fixed definition? Yes and no.
“Modern and contemporary are often transposed or used together, and that’s because typically consumers don’t know the differences,” DeRusha said. “But the style itself is always changing. Trying to keep your finger on that pulse is like knowing what each manufacturer is thinking and who their innovative brains are.”
That’s because ever-changing technology and functional engineering constitute a big part of contemporary style and design, DeRusha explained. Cabinet hardware function has come a long way with soft-close hinges and lift-up doors, for example. These are functional upgrades but represent a new sleek aesthetic that is prominent in contemporary design.
In this episode, DeRusha and Heath discussed the old debate of form versus function in design and the newer question of whether advances in materials drive design, or do design requirements cause material evolutions.
“We are living and designing in a time that all the elements are merging in perfect harmony,” DeRusha said.
For the latest news, videos, and podcasts in the AEC Industry, be sure to subscribe to our industry publication.
Follow us on social media for the latest updates in B2B!
Twitter – @AECMKSL
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale
As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…
As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…
In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…
In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…
For companies exploring a new finishing system, touring an active IntelliFinishing installation can provide valuable insight into how the system performs in real-world conditions. IntelliFinishing has systems in operation across the Midwest and in parts of the East Coast, many of which are open for prospective customers to visit. Popular tour locations include systems…
When it comes to building a complete IntelliFinishing system, Midwest Finishing Systems is a key partner—and for good reason. As John Claman of IntelliFinishing explains, the partnership isn’t just based on quality equipment, but on years of close collaboration and a shared commitment to delivering top-tier finishing systems. One of the biggest advantages of working…
